Company Filing History:
Years Active: 2021
Title: Patricia Espinheira De Sá Maciel: Innovator in Neurodegenerative Disease Treatment
Introduction
Patricia Espinheira De Sá Maciel is a prominent inventor based in Oporto, Portugal. She has made significant contributions to the field of neurodegenerative diseases through her innovative research and patent work. Her dedication to improving treatment options for these conditions has garnered attention in the scientific community.
Latest Patents
Patricia holds a patent for the use of citalopram or escitalopram, along with their pharmaceutically acceptable salts or derivatives, in the treatment of neurodegenerative diseases. This patent focuses on the positive influence of these compounds on reducing protein misfolding and aggregation, particularly through oral administration. This groundbreaking work has the potential to change the landscape of treatment for neurodegenerative disorders.
Career Highlights
Patricia is affiliated with the University of Minho, where she continues her research and development efforts. Her work is characterized by a commitment to advancing medical science and improving patient outcomes. With one patent to her name, she stands out as a key figure in her field.
Collaborations
Patricia has collaborated with notable colleagues, including Andreia Cristiana Teixeira De Castro and Ana Luísa De Jales Monteiro De Sousa. These partnerships have enriched her research and contributed to the advancement of knowledge in neurodegenerative disease treatment.
Conclusion
Patricia Espinheira De Sá Maciel is a trailblazer in the field of neurodegenerative disease treatment, with a focus on innovative pharmaceutical applications. Her work exemplifies the impact of dedicated research on improving health outcomes for patients.